1. Suven Life Sciences
stock logo

100% Buy

Suven Life Sciences Share Price

SUVEN

₹134.70-₹7.45 (-5.24%) TodayLast updated on 07 Oct, 2024 | 15:50 IST
Please wait...
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹3,100 Crs

Open

₹142.15

Close

₹142.15

Circuit range

₹161.64 - ₹107.76

Day range

₹130.00 - ₹142.75

Year range

₹60.75 - ₹169.30

Volume

4,50,575

Avg. traded

₹135.48

Revenue (12m)

₹9 Crs

Suven Life SciencesSuven Life Sciences Limited is an India-based biopharmaceutical company, which is engaged in drug discovery and development of new chemical entities (NCEs) in central nervous system (CNS) disorders targeting unmet medical needs, globally. The Company's lead clinical-stage assets include Masupirdine (Pure 5-HT 6 receptor antagonist), Samelisant (Histamine 3 receptor inverse agonist) and Ropanicant (?4?2 antagonist). Masupirdine is an ongoing phase III study for agitation and aggression in Alzheimer's type dementias in North America and Europe. Samelisant is a study on the treatment of excessive daytime sleepiness (EDS) in adult narcolepsy patients with and without cataplexy. Ropanicant is an ongoing screening for Phase II open label study for moderate to severe major depressive disorder in United States. Its other clinical-stage assets include Usmarapride (5-HT4 receptor agonist), SUVN-I6107 (True muscarinic M1 positive allosteric modulator) and SUVN-D1044 (5-HT4 receptor agonist).

Suven Life Sciences Key indicators

arrow

52 week high

₹169.30

52 week low

₹60.75

P/E ratio

P/B ratio

12.78

ROE

-0.94%

ROCE

-1.03%

Dividend yield

--

Debt/Equity ratio

EPS

-0.37

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

-83.17%

Net profit margin

-68.49%

ROE

-0.94%

ROA

-0.89%

ROCE

-1.03%

Learn more

Suven Life Sciences Shareholder returns

arrow

1 day

-5.24%

1 week

-5.87%

1 month

-10.54%

3 months

+5.71%

1 year

+87.87%

3 years

+13.43%

5 years

-48.54%

Suven Life Sciences Share Price history

arrow
DayOpenCloseDay’s change
Mon, Oct 7 2024
₹142.15
₹134.70
-5.24%
Fri, Oct 4 2024
₹141.50
₹142.15
+0.22%
Thu, Oct 3 2024
₹141.07
₹141.84
-2.86%
Tue, Oct 1 2024
₹140.70
₹146.02
+3.79%
Mon, Sep 30 2024
₹144.00
₹140.69
-1.68%
Fri, Sep 27 2024
₹142.00
₹143.10
+1.57%
Thu, Sep 26 2024
₹143.70
₹140.89
-1.96%
Wed, Sep 25 2024
₹147.70
₹143.70
-2.24%

Shareholding info

arrow

Promoters (70.27%)

Mutual Funds (1.05%)

Retail and other (28.23%)

Foreign institutions-FII (0.45%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Rights Issue • 1:2

    Ex date 17 Oct 2022

    expand tab

Learn more

Frequently asked questions